Extracellular and Intracellular Actions of Sphingosine-1-phosphate

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2010 Oct 6

PMID 20919652

Citations 172

Authors

Graham M Strub

Michael Maceyka

Nitai C Hait

Sheldon Milstien

Sarah Spiegel

Affiliations

Soon will be listed here.

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator with crucial roles in a wide variety of cellular functions across a broad range of organisms. Though a simple molecule in structure, S1P functions are complex. The formation of S1P is catalyzed by one of two sphingosine kinases that have differential cellular distributions as well as both overlapping and opposing functions and which are activated by many different stimuli. S1P can act on a family of G protein-coupled receptors (S1PRs) that are also differentially expressed in different cell types, which influences the cellular responses to S1P. In addition to acting on receptors located on the plasma membrane, S1P can also function inside the cell, independently of S1PRs. It also appears that both the intracellular location and the isotype of sphingosine kinase involved are major determinants of inside-out signaling of S1P in response to many extracellular stimuli. This chapter is focused on the current literature on extracellular and intracellular actions of S1P.

Citing Articles

Sphingosine kinase 1 inhibition aggravates vascular smooth muscle cell calcification.

Razazian M, Bahiraii S, Jannat I, Tiffner A, Beilhack G, Levkau B Pflugers Arch. 2025; .

PMID: 39899071 DOI: 10.1007/s00424-025-03068-6.

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.

Fu F, Li W, Zheng X, Wu Y, Du D, Han C Int J Mol Sci. 2024; 25(21).

PMID: 39519028 PMC: 11545938. DOI: 10.3390/ijms252111474.

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?.

Foran D, Antoniades C, Akoumianakis I Nutrients. 2024; 16(19).

PMID: 39408263 PMC: 11478599. DOI: 10.3390/nu16193296.

A role for plasma membrane Ca ATPases in regulation of cellular Ca homeostasis by sphingosine kinase-1.

Volk L, Bruun J, Trautmann S, Thomas D, Schwalm S, Pfeilschifter J Pflugers Arch. 2024; 476(12):1895-1911.

PMID: 39392480 PMC: 11582158. DOI: 10.1007/s00424-024-03027-7.

Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model.

Sudhadevi T, Annadi A, Basa P, Jafri A, Natarajan V, Harijith A J Appl Physiol (1985). 2024; 137(5):1231-1242.

PMID: 39262336 PMC: 11563639. DOI: 10.1152/japplphysiol.00311.2024.

References

Oskeritzian C, Alvarez S, Hait N, Price M, Milstien S, Spiegel S . Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood. 2008; 111(8):4193-200. PMC: 2971746. DOI: 10.1182/blood-2007-09-115451. View

Hayashi S, Okada T, Igarashi N, Fujita T, Jahangeer S, Nakamura S . Identification and characterization of RPK118, a novel sphingosine kinase-1-binding protein. J Biol Chem. 2002; 277(36):33319-24. DOI: 10.1074/jbc.M201442200. View

Kohama T, Olivera A, Edsall L, Nagiec M, Dickson R, Spiegel S . Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem. 1998; 273(37):23722-8. DOI: 10.1074/jbc.273.37.23722. View

Venkataraman K, Thangada S, Michaud J, Oo M, Ai Y, Lee Y . Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J. 2006; 397(3):461-71. PMC: 1533315. DOI: 10.1042/BJ20060251. View

Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F . Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal. 2006; 19(4):748-60. DOI: 10.1016/j.cellsig.2006.09.004. View

Van Brocklyn J, Graler M, Bernhardt G, Hobson J, Lipp M, Spiegel S . Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood. 2001; 95(8):2624-9. View

Morita Y, Perez G, Paris F, Miranda S, Ehleiter D, Haimovitz-Friedman A . Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000; 6(10):1109-14. DOI: 10.1038/80442. View

Cuvillier O, Pirianov G, Kleuser B, Vanek P, Coso O, Gutkind S . Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996; 381(6585):800-3. DOI: 10.1038/381800a0. View

Mao C, Saba J, Obeid L . The dihydrosphingosine-1-phosphate phosphatases of Saccharomyces cerevisiae are important regulators of cell proliferation and heat stress responses. Biochem J. 1999; 342 Pt 3:667-75. PMC: 1220508. View

10.

Itagaki K, Yun J, Hengst J, Yatani A, Hauser C, Spolarics Z . Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism. J Pharmacol Exp Ther. 2007; 323(1):186-91. DOI: 10.1124/jpet.107.121210. View

11.

Gonda K, Okamoto H, Takuwa N, Yatomi Y, Okazaki H, Sakurai T . The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem J. 1998; 337 ( Pt 1):67-75. PMC: 1219937. View

12.

Singleton P, Dudek S, Ma S, Garcia J . Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem. 2006; 281(45):34381-93. DOI: 10.1074/jbc.M603680200. View

13.

Van Brocklyn J, Lee M, Menzeleev R, Olivera A, Edsall L, Cuvillier O . Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol. 1998; 142(1):229-40. PMC: 2133030. DOI: 10.1083/jcb.142.1.229. View

14.

Singleton P, Dudek S, Chiang E, Garcia J . Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 2005; 19(12):1646-56. DOI: 10.1096/fj.05-3928com. View

15.

Sanchez T, Estrada-Hernandez T, Paik J, Wu M, Venkataraman K, Brinkmann V . Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem. 2003; 278(47):47281-90. DOI: 10.1074/jbc.M306896200. View

16.

Laviad E, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill Jr A . Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem. 2008; 283(9):5677-84. DOI: 10.1074/jbc.M707386200. View

17.

Finigan J, Dudek S, Singleton P, Chiang E, Jacobson J, Camp S . Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem. 2005; 280(17):17286-93. DOI: 10.1074/jbc.M412427200. View

18.

Maceyka M, Sankala H, Hait N, Le Stunff H, Liu H, Toman R . SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem. 2005; 280(44):37118-29. DOI: 10.1074/jbc.M502207200. View

19.

Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S . Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999; 147(3):545-58. PMC: 2151183. DOI: 10.1083/jcb.147.3.545. View

20.

McVerry B, Garcia J . In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal. 2004; 17(2):131-9. DOI: 10.1016/j.cellsig.2004.08.006. View